- Home
- BLNK vs MGTX Comparison
BLNK vs MGTX Comparison
Compare BLNK & MGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLNK
- MGTX
- Stock Information
- Founded
- BLNK 2009
- MGTX 2015
- Country
- BLNK United States
- MGTX United States
- Employees
- BLNK N/A
- MGTX N/A
- Industry
- BLNK Industrial Specialties
- MGTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BLNK Consumer Discretionary
- MGTX Health Care
- Exchange
- BLNK Nasdaq
- MGTX Nasdaq
- Market Cap
- BLNK 295.1M
- MGTX 411.4M
- IPO Year
- BLNK N/A
- MGTX N/A
- Fundamental
- Price
- BLNK $2.11
- MGTX $5.99
- Analyst Decision
- BLNK Strong Buy
- MGTX Strong Buy
- Analyst Count
- BLNK 7
- MGTX 2
- Target Price
- BLNK $5.79
- MGTX $22.50
- AVG Volume (30 Days)
- BLNK 4.4M
- MGTX 322.0K
- Earning Date
- BLNK 11-07-2024
- MGTX 11-12-2024
- Dividend Yield
- BLNK N/A
- MGTX N/A
- EPS Growth
- BLNK N/A
- MGTX N/A
- EPS
- BLNK N/A
- MGTX N/A
- Revenue
- BLNK $156,918,000.00
- MGTX $8,122,000.00
- Revenue This Year
- BLNK $6.96
- MGTX $133.83
- Revenue Next Year
- BLNK $31.64
- MGTX $655.34
- P/E Ratio
- BLNK N/A
- MGTX N/A
- Revenue Growth
- BLNK 66.29
- MGTX 26.87
- 52 Week Low
- BLNK $1.53
- MGTX $3.49
- 52 Week High
- BLNK $4.66
- MGTX $7.60
- Technical
- Relative Strength Index (RSI)
- BLNK 62.35
- MGTX 78.52
- Support Level
- BLNK $1.63
- MGTX $3.97
- Resistance Level
- BLNK $2.14
- MGTX $6.07
- Average True Range (ATR)
- BLNK 0.12
- MGTX 0.33
- MACD
- BLNK 0.04
- MGTX 0.22
- Stochastic Oscillator
- BLNK 94.12
- MGTX 89.00
About BLNK Blink Charging Co.
Blink Charging Co is an owner, operator, and provider of electric vehicle (EV) charging services. The company offers both residential and commercial EV charging equipment, enabling EV drivers to easily recharge at various location types. The company's business is the sale and distribution of electric vehicle charging equipment and its associated revenues earned from customers and/or Property Partners who use equipment connected to its network. It earns majority revenue from U.S.A.
About MGTX MeiraGTx Holdings plc
MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The company's pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it operates in the United States, the United Kingdom, and European Union.